🐜
|
Minimal disease activity and impact of disease in psoriatic arthritis: a Spanish cross-sectional multicenter study
28 auth.
R. Queiró,
J. Cañete,
C. Montilla,
M. Abad,
M. Montoro,
S. Gómez,
A. Cábez,
J. C. Torre Alonso,
J. Román-Ivorra,
J. Sanz,
J. Salvatierra,
J. Calvo-Alén,
A. Sellas,
F. Rodríguez,
A. Bermúdez,
...
M. Romero,
M. Riesco,
J. C. Cobeta,
F. Medina,
A. Aragon,
M. García,
A. Urruticoechea,
C. González,
E. Júdez,
B. González,
P. Fernández,
L. Pantoja,
R. Morlà
|
6 |
2017 |
6 🐜
|
🐢
|
Drug outcome survey to evaluate anti-TNF treatment in rheumatoid arthritis: an Italian observational study (the DOSE study).
C. Anecchino,
C. Fanizza,
V. Marino,
M. Romero
|
3 |
2015 |
3 🐢
|
🐜
|
Disease features associated with a low disease impact in patients with psoriatic arthritis: results of a cross-sectional multicenter study
28 auth.
R. Queiró,
J. Cañete,
M. Montoro,
S. Gómez,
A. Cábez,
Carlos Miguel Angel Juan Carlos Jose Andrés Jesús Juan Ja Montilla Abad Torre-Alonso Román-Ivorra Sanz Salva,
C. Montilla,
M. Abad,
J. C. Torre-Alonso,
J. Román-Ivorra,
J. Sanz,
J. Salvatierra,
J. Calvo-Alén,
A. Sellas,
F. Rodríguez,
...
A. Bermúdez,
M. Romero,
M. Riesco,
J. C. Cobeta,
F. Medina,
M. García,
A. Urruticoechea,
Carlos M González,
E. Júdez,
B. González,
P. Fernández,
L. Pantoja,
R. Morlà
|
3 |
2020 |
3 🐜
|
🐜
|
FRI0514 Psoriatic arthritis is associated with diagnostic delay and worse outcome at three months when compared to rheumatoid arthritis: results from the uk national audit for inflammatory arthritis
22 auth.
R. Queiró,
Juan D Cañete,
C. Montilla,
M. Abad,
M. Montoro,
S. Gόmez,
A. Cábez,
J. Alonso,
J. Ivorra,
J. Sanz,
...
J. Salvatierra,
J. A. Calvo,
A. Sellas,
Francisco Rodriguez,
A. Bermúdez,
M. Romero,
M. Riesco,
JC Cobeta,
F. Medina,
A. Aragόn,
Mercedes García,
A. Urruticoechea
|
2 |
2017 |
2 🐜
|
🐜
|
AB0171 Muscle atrophy in murine model of arthritis is related to disease score
7 auth.
L. Filippin,
V. de Oliveira Nunes Teixeira,
P. Lora,
P. Viacava,
L. Xavier,
M. Romero,
...
R. Xavier
|
0 |
2013 |
0 🐜
|